Members > Members

Database of members

Search here for BioWin’s business members.

Would you like to become a member of BioWin and give your company the benefit of the advantages that the cluster offers?  Follow the registration process here.

Click here to download the presentation of BioWin's members in Chinese.


Print
MDxHealth (Oncomethylome Sciences) S.A.
Company MDxHealth (Oncomethylome Sciences) S.A.
Address Tour 5 GIGA Niveau +3 - Avenue de l'Hopîtal, 11
4000 LIEGE
BELGIUM
Phone +32 4.364 20 70
Fax +32 4 364 20 71
VAT number BE-479292440
Email sandra.huygen@mdxhealth.com
Website http://www.mdxhealth.com/
Contact HUYGEN Sandra
Activity sector
  • Diagnostic
Expertise sector
  • Bioinformatics
  • Diagnostics
  • High-throughput screening
  • Cancer
  • Clinical
  • Development
  • Discovery
  • Pre-clinical
Activity MDxHealth is a leading molecular diagnostics company that develops and commercializes oncology-based molecular diagnostic testing for personalized medicine. The company’s tests are based on patented gene methylation technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. MDxHealth uses a molecular (gene-based) technology to improve cancer diagnosis and treatment. Gene methylation is a control mechanism that regulates gene expression in DNA and occurs when a methyl group is added to 1 of the 4 building blocks of DNA, a cytosine. In several diseases, however, the promoter regions that carry the instructions to produce an essential protein can be over- or hypermethylated, effectively inhibiting protein production. Hypermethylation, such as tumor suppressor genes, is associated with the presence and development of most cancers.
 
  Back to list  
  Next member  

In the search engine : "Field of activity", the members are classified according to the type of organisation (companies, universities, research units,..) 
In the search engine : "keyword", you may type any word too find out all kind of organisations active in that domain (bioinformatics, pre-clinical, cancer, ...)